Peer Review History
| Original SubmissionDecember 12, 2024 |
|---|
|
PONE-D-24-54958Modeling disorders of consciousness at the patient level reveals the network's influence on the diagnosis vs the local node parameters role in prognosisPLOS ONE Dear Dr. Zonca, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Apr 25 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Marie-Constance Corsi Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1.Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. Please note that funding information should not appear in any section or other areas of your manuscript. We will only publish funding information present in the Funding Statement section of the online submission form. Please remove any funding-related text from the manuscript. 3. Thank you for stating the following financial disclosure: “LZ was supported by the FLAG-ERA JTC2021 project ModelDXConsciousness (Human Brain Project Partnering Project) Grant PCI2021-122019-2A funded by MICIU/AEI /10.13039/501100011033 and by the European Union NextGenerationEU/PRTR. AE was supported by the project eBRAIN-Health—Actionable Multilevel Health Data (id 101058516), funded by EU Horizon Europe and by the Grant PID2022-136216NBI00, funded by MICIU/AEI/10.13039/501100011033, and “ERDF A way of making Europe”, ERDF, EU. YSP was supported by the project NEurological MEchanismS of Injury, and the project Sleep-like cellular dynamics (NEMESIS) (ref. 101071900) funded by the EU ERC Synergy Horizon Europe. GD was supported by the project NEurological MEchanismS of Injury, and the project Sleep-like cellular dynamics (NEMESIS) (ref. 101071900) funded by the EU ERC Synergy Horizon Europe and and by the Grant PID2022-136216NB-I00, funded by MICIU/AEI/10.13039/501100011033, and “ERDF A way of making Europe”, ERDF, EU. This research was partially funded by Grant PID2021-122136OB-C22 funded by MICIU/AEI/10.13039/501100011033 and by ERDF A way of making Europe for GP. DM received individual funding from Ecole Doctorale Frontières de l’Innovation en Recherche et Education–Programme Bettencourt. DM and JDS were supported by funding from the EU ERAPerMed Joint Translational Call for Proposals for “Personalised Medicine: Multidisciplinary research towards implementation” (ERA PerMed JTC2019). JDS was also supported by the FLAG-ERA JTC2021 project ModelDXConsciousness (Human Brain Project Partnering Project). The study was further supported by the University and University Hospital of Liège, the BIAL Foundation, the Belgian National Funds for Scientific Research (FRS-FNRS), the FNRS PDR project (T.0134.21), the FLAG-ERA JTC2021 project ModelDXConsciousness (Human Brain Project Partnering Project) and FLAG-ERA JTC 2023 - HBP - Basic and Applied Research, project BrainAct, JTC the fund Generet, the King Baudouin Foundation, the Funds Chantal Schaeck Yolande, the Télévie Foundation, the European Space Agency (ESA) and the Belgian Federal Science Policy Office (BELSPO) in the framework of the PRODEX Programme, the Public Utility Foundation ‘Université Européenne du Travail’, “Fondazione Europea di Ricerca Biomedica”, the BIAL Foundation, the Mind Science Foundation, the European Commission, the Fondation Leon Fredericq, the Mind-Care foundation, the National Natural Science Foundation of China (Joint Research Project 81471100) and the European Foundation of Biomedical Research FERB Onlus, the Horizon 2020 MSCA – Research and Innovation Staff Exchange DoC-Box project (HORIZON-MSCA-2022-SE-01-01; 101131344). OG is Research Associate at FRS-FNRS. JA is postdoctoral fellow funded (1265522N) by the Fund for Scientific Research-Flanders (FWO).” Please state what role the funders took in the study. If the funders had no role, please state: "The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript." If this statement is not correct you must amend it as needed. Please include this amended Role of Funder statement in your cover letter; we will change the online submission form on your behalf. 4. When completing the data availability statement of the submission form, you indicated that you will make your data available on acceptance. We strongly recommend all authors decide on a data sharing plan before acceptance, as the process can be lengthy and hold up publication timelines. Please note that, though access restrictions are acceptable now, your entire data will need to be made freely accessible if your manuscript is accepted for publication. This policy applies to all data except where public deposition would breach compliance with the protocol approved by your research ethics board. If you are unable to adhere to our open data policy, please kindly revise your statement to explain your reasoning and we will seek the editor's input on an exemption. Please be assured that, once you have provided your new statement, the assessment of your exemption will not hold up the peer review process. 5. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: The manuscript presents a framework for modeling disorders of consciousness (DoC) at the individual patient level by combining dimensionality reduction techniques and biologically inspired whole-brain modeling. The main finding—that connectivity matrices and local parameters carry complementary information regarding the patient's diagnosis and prognosis—is highly relevant. The strengths of this study are manifold. The latent space framework, employed in recent publications from the same team, simplifies data complexity while retaining essential diagnostic features, demonstrating robustness across different datasets, including the two DoC datasets analyzed in the present manuscript. Connectivity-based brain models are then simulated to reproduce the latent dynamics in silico. The authors employ a recently introduced astrocyte-inspired model (AHP) alongside the more established Hopf model. Integrating biologically meaningful parameters, such as those derived from the AHP model, is another major contribution, as it offers a pathway to understanding underlying brain mechanisms disrupted in DoC, as the authors underscore in the discussion. The authors have made the pipeline available, which helps transparency. The potential applications of model-based biomarkers (e.g., connectivity and local node parameters), both in clinical decision-making and personalized treatment, highlight the broad interest of this work. Despite its strengths, the manuscript needs significant revisions to enhance clarity and methodological robustness. 1) One major issue pertains to the connectivity analysis and its application across datasets. It is unclear whether the authors applied the analysis to both the Paris and Liege datasets or only to one of them. If (as I understand) both datasets are used for the results in Figure 3, mixing CNT, MCS, and UWS groups from two different datasets could result in spurious classification, as the datasets are acquired at different resolutions using different pipelines (despite the latent space method, which might partly suppress these differences). Confirming the effectiveness of the classification separately on the two datasets would strengthen the validity of the results. 2) Another area that needs further clarification is the interpretation of connectivity results. The manuscript identifies positive and negative connections within the generative effective connectivity (GEC) matrices but stops short of exploring their interpretation. A discussion on the meaning of positive inter-clique links and negative intra-clique links would enrich the study. For instance, mapping the latent modes back to standard resting state networks (as in Sanz-Perl et al Network Neuroscience 2025) could provide neuroscientific interpretability, helping to connect the findings (about the modular interaction of two cliques) with existing functional network frameworks. 3) The clustering of patients into groups with different outcomes is intriguing but requires a more detailed quantification. For example, the interpretation of Fig.4C reports that “clusters 2 and 3 contain mainly patients with negative outcomes, cluster 1 contains a majority of emerged patients, and clusters 0 and 4 contain more mixed outcomes”. However, there are no numbers displayed to assess if the percentages support the analysis by visual inspection. 4) The manuscript does not provide a rationale for the choice of fixing the global coupling (G=1). Since G is generally regarded as a crucial parameter that influences global network dynamics, wouldn’t it be beneficial to include it in the iterative fitting process alongside local parameters? It would be helpful if the authors provided a justification for why G is held constant. 5) The Methods section would benefit from greater transparency and detail. Key metrics, such as the structural similarity index (SSIM), are referenced but not explicitly defined. Including a brief description of the SSIM formula would make the study self-contained. Similarly, the procedures for fitting model parameters and the rationale behind the specific GEC formula are not described with sufficient clarity. While it is reasonable to reference prior work for context, the paper would be easier to follow if these core methods were explicitly presented. 6) Beyond methodological issues, the manuscript’s writing could be improved to enhance readability. The use of inconsistent tenses, punctuation errors, and occasional typos (e.g., “…simulations is Nmax is reached”, or “. Where the shifted matrices are obtained..”, or “using the edge_boundary function”) detract from the clarity of the scientific content. I recommend using tools like Grammarly to identify and correct these issues. Additionally, some sentences are overly verbose or unclear, such as “Moreover, analysis of the clusters’ separability also revealed which parameter, or group of parameters, were leading to belong to which cluster” which could be rephrased more concisely. A thorough revision for grammar, style (e.g., reducing the excessive use of the Saxon genitive 's), and logical flow would make the paper more accessible to the reader and better communicate its scientific value. 7) A revised title might help improve the paper's visibility. The current title, “Modeling disorders of consciousness at the patient level reveals the network's influence on the diagnosis vs the local node parameters role in prognosis”, feels a bit lengthy. Additionally, using “vs” is not ideal. You might consider something like: “Personalized models of Disorders of Consciousness reveal complementary roles of connectivity and local parameters in diagnosis and prognosis”. 8) The figures, while generally informative, also require some adjustments. Missing labels, such as for the clusters’ IDs, or the absent color bar in functional connectivity figures, should be added to ensure clarity. In Figure 4A, the yellow cluster is nearly invisible, making it difficult to interpret the results. Adjusting the color palette or improving the visual contrast would address this issue. Figure S2 title should be “GEC-based biomarkers for the Hopf model:” and panel C should be adjusted in the caption “bf C.”. 9) Notice that PONE guidelines specify that “If there are restrictions on publicly sharing data […] those must be specified.” In conclusion, this study presents a promising framework for analyzing DoC patients, combining innovative methodologies with biologically grounded insights. However, substantial revisions are required to address the issues outlined above. Expanding the connectivity analysis to both datasets or justifying their combined analysis would enhance the manuscript's robustness, while clearer interpretations and improved methodology transparency will help realize the full potential of this promising framework. I hope that these comments will assist in improving the manuscript. Sincerely, Giovanni Rabuffo ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: Yes: Giovanni Rabuffo ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.
|
| Revision 1 |
|
PONE-D-24-54958R1Personalized models of Disorders of Consciousness reveal complementary roles of connectivity and local parameters in diagnosis and prognosisPLOS ONE Dear Dr. Zonca, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Jul 30 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Marie-Constance Corsi Academic Editor PLOS ONE Journal Requirements: Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. Additional Editor Comments (if provided): [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: (No Response) ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: Yes: Giovanni Rabuffo ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.
|
| Revision 2 |
|
Personalized models of Disorders of Consciousness reveal complementary roles of connectivity and local parameters in diagnosis and prognosis PONE-D-24-54958R2 Dear Dr. Zonca, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. If you have any questions relating to publication charges, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Marie-Constance Corsi Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: |
| Formally Accepted |
|
PONE-D-24-54958R2 PLOS ONE Dear Dr. Zonca, I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team. At this stage, our production department will prepare your paper for publication. This includes ensuring the following: * All references, tables, and figures are properly cited * All relevant supporting information is included in the manuscript submission, * There are no issues that prevent the paper from being properly typeset You will receive further instructions from the production team, including instructions on how to review your proof when it is ready. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few days to review your paper and let you know the next and final steps. Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. You will receive an invoice from PLOS for your publication fee after your manuscript has reached the completed accept phase. If you receive an email requesting payment before acceptance or for any other service, this may be a phishing scheme. Learn how to identify phishing emails and protect your accounts at https://explore.plos.org/phishing. If we can help with anything else, please email us at customercare@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Marie-Constance Corsi Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .